-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R374JODo12vxmRQHtDQGY7yirHuDuORlLxw0ITHkvZRA4omgw/gcCqn997PmkFQr mSd7FH4Dqh9b4t6Lzpqshw== 0000950133-07-002306.txt : 20070511 0000950133-07-002306.hdr.sgml : 20070511 20070511160124 ACCESSION NUMBER: 0000950133-07-002306 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070331 FILED AS OF DATE: 20070511 DATE AS OF CHANGE: 20070511 EFFECTIVENESS DATE: 20070511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06964 FILM NUMBER: 07842372 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 13F-HR 1 w35020ae13fvhr.txt FORM 13F HOLDINGS REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: March 31, 2007 Check here if Amendment [ ]; Amendment Number: -------- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger Title: SIGNING AUTHORITY Phone: 41 (01) 267 67 00 Signature, Place, and Date of Signing: /s/ Adrian Bruengger ----------------------------------------- Schaffhausen, Switzerland, May 10, 2007 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) 1 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 3 Form 13F Information Table Entry Total: 17 Form 13F Information Table Value Total: $1,382,828 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 28-11193 Biotech Focus N.V. 2 28-11191 Biotech Invest N.V. 3 28-11189 Biotech Target N.V. 2 BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - -------------------------------------------------------------------------------------------------------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP [x$1000] PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - -------------------------------------------------------------------------------------------------------------- Affymetrix COM 00826T108 60,140 2,000,000 SH DEFINED 1 2,000,000 NONE NONE Amgen COM 031162100 27,940 500,000 SH DEFINED 1 500,000 NONE NONE Anadys Pharmaceuticals COM 03252Q408 265 66,800 SH DEFINED 3 66,800 NONE NONE Arena Pharmaceuticals COM 040047102 10,860 1,000,000 SH DEFINED 3 1,000,000 NONE NONE Biogen Idec COM 09062X103 138,258 3,115,320 SH DEFINED 1 3,115,320 NONE NONE Celgene COM 151020104 341,905 6,517,439 SH DEFINED 2 6,517,439 NONE NONE Elan Corp ADR 284131208 51,602 3,882,755 SH DEFINED 2 3,882,755 NONE NONE Genentech COM 368710406 242,468 2,952,600 SH DEFINED 1 2,952,600 NONE NONE Genzyme COM 372917104 69,178 1,152,584 SH DEFINED 1 1,152,584 NONE NONE Gilead COM 375558103 249,198 3,251,109 SH DEFINED 1 3,251,109 NONE NONE Incyte COM 45337C102 6,242 947,166 SH DEFINED 3 947,166 NONE NONE Keryx Biopharmaceuticals COM 492515101 9,882 939,311 SH DEFINED 3 939,311 NONE NONE Optimer Pharmaceuticals COM 68401H104 3,884 400,000 SH DEFINED 3 400,000 NONE NONE Rigel Pharmaceuticals COM 766559603 10,860 1,000,000 SH DEFINED 3 1,000,000 NONE NONE The Medicines Company COM 584688105 27,588 1,100,000 SH DEFINED 3 1,100,000 NONE NONE Vertex Pharmaceuticals COM 92532F100 87,434 3,118,200 SH DEFINED 3 3,118,200 NONE NONE Zymogenetics COM 98985T109 45,124 2,900,000 SH DEFINED 3 2,900,000 NONE NONE
3 -----END PRIVACY-ENHANCED MESSAGE-----